Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |